An integrated, rule-based informatics system demonstrated its capacity to leverage electronic health records to streamline ...

The study is among the first to look at the potential impacts of clonal dynamics on patients with lower-risk myelodysplastic ...

Here are 5 key points for pre–breast screening preparation that cover the areas of risk assessment, lifestyle adjustments, ...

An August 2024 update to the National Comprehensive Cancer Network (NCCN) clinical practice guidelines for treatment of ...

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses the potential of tailored treatment strategies and the importance of smoking cessation.

CMS released a preliminary list of 101 generic drugs for its Medicare $2 Drug List Model, which aims to cap out-of-pocket ...

National Oncology Conference (NOC) began with a diverse range of poster exhibits, highlighting important initiatives in ...

Two posters highlighted the effects of sacubitril/valsartan (Entresto; Novartis) on key biomarkers and cardiac function in ...

The prior authorization process for patients with cancer demonstrates fewer days until submission and lower denial rates for Asian patients relative to White patients.

Panelists discuss how the ADRIATIC trial investigating durvalumab in limited-stage small cell lung cancer (SCLC) has shown promising results, potentially addressing unmet needs in this patient ...

Panelists discuss the differences in efficacy and safety profiles between belimumab and voclosporin for lupus nephritis (LN) and how payers are evaluating their value, including considerations of cost ...

Panelists discuss how atezolizumab is being investigated in the NRG-LU005 trial for limited-stage small cell lung cancer (SCLC), comparing its trial design with that of the ADRIATIC study, while also ...